{"id":159657,"date":"2025-11-03T01:24:17","date_gmt":"2025-11-03T01:24:17","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/159657\/"},"modified":"2025-11-03T01:24:17","modified_gmt":"2025-11-03T01:24:17","slug":"health-care-roundup-market-talk-5","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/159657\/","title":{"rendered":"Health Care Roundup: Market Talk"},"content":{"rendered":"<p data-type=\"paragraph\" data=\"[object Object]\" class=\"css-1akm6h5-Paragraph e1e4oisd0\">The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.<\/p>\n<p data-type=\"paragraph\" data=\"[object Object]\" class=\"css-1akm6h5-Paragraph e1e4oisd0\">1329 ET \u2013 Eli Lilly\u2019s direct channel sales are reducing obstacles to access GLP-1 drugs, helping it grow the total market, the company says on its analyst call. \u201cThere is significant demand in the consumer segment related to finding ways to get outside some of the frictions in the health care system,\u201d Lily USA President Ilya Yuffa says. \u201cWe\u2019re seeing significantly more volume go through a direct-to-consumer platform with Lilly Direct.\u201d The company also said this week patients would be able to pick up Zepbound vials at Walmart. That accessibility is \u201can important element for us to expand the ability for patients to get treated,\u201d Yuffa says. (<a data-type=\"link\" href=\"https:\/\/www.wsj.com\/health\/mailto:nicholas.miller@wsj.com\" target=\"_blank\" class=\"ekxajjj0 css-i0lbhy-OverridedLink\" rel=\"nofollow noopener\">nicholas.miller@wsj.com<\/a>)<\/p>\n<p class=\"css-16aepit e1jdulti0\">Copyright \u00a92025 Dow Jones &amp; Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8<\/p>\n","protected":false},"excerpt":{"rendered":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET,&hellip;\n","protected":false},"author":2,"featured_media":159658,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[275],"tags":[7823,41563,41562,41573,41570,13782,41564,91001,41565,6738,18,41571,14480,3334,20602,135,475,474,82483,19,41586,17,3544,3521,92835,6403,82656,69291,13248,82482,41561,2900,7840,87959,9436,44285,11994,44282,12896,41585,26243,642,41580],"class_list":{"0":"post-159657","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-healthcare","8":"tag-acquisitions","9":"tag-acquisitions-mergers","10":"tag-acquisitions-mergers-shareholdings","11":"tag-ce-industry-news-filter","12":"tag-content-types","13":"tag-corporate","14":"tag-corporate-actions","15":"tag-corporate-digests","16":"tag-corporate-industrial-news","17":"tag-earnings","18":"tag-eire","19":"tag-factiva-filters","20":"tag-financial-performance","21":"tag-general-news","22":"tag-government-policy","23":"tag-health","24":"tag-health-care","25":"tag-healthcare","26":"tag-healthcare-life-sciences","27":"tag-ie","28":"tag-industrial-news","29":"tag-ireland","30":"tag-life-sciences","31":"tag-lifestyle","32":"tag-linkendrnrealtime-linkedarticle-dnco20251030017792","33":"tag-living","34":"tag-living-lifestyle","35":"tag-mental-fitness","36":"tag-mergers","37":"tag-newsplus","38":"tag-ownership-changes","39":"tag-pharmaceuticals","40":"tag-physical","41":"tag-physical-mental-fitness","42":"tag-political","43":"tag-political-general-news","44":"tag-regulation","45":"tag-regulation-government-policy","46":"tag-sales-figures","47":"tag-shareholdings","48":"tag-synd","49":"tag-weight-management","50":"tag-wsj-pro-wsj-com"},"share_on_mastodon":{"url":"","error":"Validation failed: Text character limit of 500 exceeded"},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/159657","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=159657"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/159657\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/159658"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=159657"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=159657"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=159657"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}